Search Results - "Papanicolaou, Genovefa A."

Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update by Royston, Léna, Papanicolaou, Genovefa A, Neofytos, Dionysios

“…Despite the significant progress made, CMV infection is one of the most frequent infectious complications in transplant recipients. CMV infections that become…”
Get full text

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients by Stadtmauer, Edward A., Sullivan, Keith M., Marty, Francisco M., Dadwal, Sanjeet S., Papanicolaou, Genovefa A., Shea, Thomas C., Mossad, Sherif B., Andreadis, Charalambos, Young, Jo-Anne H., Buadi, Francis K., El Idrissi, Mohamed, Heineman, Thomas C., Berkowitz, Elchonon M.

“…Recombinant herpes zoster (HZ) vaccines may be an alternative to the live-attenuated HZ vaccine for immunocompromised individuals. This was a phase 1/2,…”
Get full text

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant by Prockop, Susan E, Hasan, Aisha, Doubrovina, Ekaterina, Dahi, Parastoo B, Rodriguez-Sanchez, Irene, Curry, Michael, Mauguen, Audrey, Papanicolaou, Genovefa A, Su, Yiqi, Yao, JinJuan, Arcila, Maria, Boulad, Farid, Castro-Malaspina, Hugo, Cho, Christina, Curran, Kevin J, Giralt, Sergio, Kernan, Nancy A, Koehne, Guenther, Jakubowski, Ann, Papadopoulos, Esperanza, Perales, Miguel-Angel, Politikos, Ioannis, Price, Keith, Selvakumar, Annamalai, Sauter, Craig S, Tamari, Roni, Vizconde, Teresa, Young, James W, O'Reilly, Richard J

“…BackgroundRefractory CMV viremia and disease are associated with significant morbidity and mortality in recipients of hematopoietic stem cell transplant…”
Get full text

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience by Lin, Andrew, Maloy, Molly, Su, Yiqi, Bhatt, Valkal, DeRespiris, Lauren, Griffin, Meagan, Lau, Carmen, Proli, Anthony, Barker, Juliet, Shaffer, Brian, Giralt, Sergio A., Jakubowski, Ann A., Papadopoulos, Esperanza B., Papanicolaou, Genovefa A., Seo, Susan K., Perales, Miguel‐Angel

“…Cytomegalovirus (CMV) is associated with significant morbidity and mortality in allogeneic hematopoietic cell transplantation (HCT) patients. We evaluated the…”
Get full text

Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients by Karandikar, Umesh C, Crawford, Sue E, Ajami, Nadim J, Murakami, Kosuke, Kou, Baijun, Ettayebi, Khalil, Papanicolaou, Genovefa A, Jongwutiwes, Ubonvan, Perales, Miguel-Angel, Shia, Jinru, Mercer, David, Finegold, Milton J, Vinjé, Jan, Atmar, Robert L, Estes, Mary K

“…Human noroviruses (HuNoVs) can often cause chronic infections in solid organ and haematopoietic stem cell transplant (HSCT) patients. Based on…”
Get full text

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial by Marty, Francisco M, Dr, Ljungman, Per, Prof, Papanicolaou, Genovefa A, MD, Winston, Drew J, MD, Chemaly, Roy F, MD, Strasfeld, Lynne, MD, Young, Jo-Anne H, MD, Rodriguez, Tulio, MD, Maertens, Johan, Prof, Schmitt, Michael, MD, Einsele, Hermann, Prof, Ferrant, Augustin, MD, Lipton, Jeffrey H, MD, Villano, Stephen A, MD, Chen, Hongzi, PhD, Boeckh, Michael, Prof

“…Summary Background Available drugs against cytomegalovirus have adverse effects that compromise their prophylactic use in recipients of allogeneic stem-cell…”
Get full text

Brincidofovir for Polyomavirus-Associated Nephropathy After Allogeneic Hematopoietic Stem Cell Transplantation by Papanicolaou, Genovefa A., MD, Lee, Yeon Joo, MD, Young, James W., MD, Seshan, Surya V., MB BS, Boruchov, Adam M., MD, Chittick, Gregory, BS, Momméja-Marin, Herve, MD, Glezerman, Ilya G., MD

“…Polyomavirus-associated nephropathy (PVAN) is common in patients who have undergone kidney transplantation and has been reported in hematopoietic stem cell…”
Get full text

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study by Winston, Drew J., Young, Jo-Anne H., Pullarkat, Vinod, Papanicolaou, Genovefa A., Vij, Ravi, Vance, Estil, Alangaden, George J., Chemaly, Roy F., Petersen, Finn, Chao, Nelson, Klein, Jared, Sprague, Kellie, Villano, Stephen A., Boeckh, Michael

“…The anti-cytomegalovirus (CMV) activity and safety of oral maribavir in CMV-seropositive allogeneic stem-cell transplant recipients were evaluated in a…”
Get full text

Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States by Papanicolaou, Genovefa A., Dvorak, Christopher C., Dadwal, Sanjeet, Maron, Gabriela, Prasad, Vinod K., Giller, Roger, Abdel‐Azim, Hisham, Sadanand, Arhanti, Casciano, Roman, Chandak, Aastha, Huang, Shengnan, Nichols, Garrett, Brundage, Tom, Vainorius, Enrikas, Mozaffari, Essy, Hutcheson, Robert

“…Background Adenovirus (AdV) is increasingly recognized as a threat to successful outcomes after allogeneic hematopoietic cell transplantation (allo‐HCT)…”
Get full text

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation by Marty, Francisco M., Winston, Drew J., Chemaly, Roy F., Mullane, Kathleen M., Shore, Tsiporah B., Papanicolaou, Genovefa A., Chittick, Greg, Brundage, Thomas M., Wilson, Chad, Morrison, Marion E., Foster, Scott A., Nichols, W. Garrett, Boeckh, Michael J.

“…•Prophylaxis with brincidofovir 100 mg twice weekly did not decrease clinically significant cytomegalovirus (CMV) infection (CMV disease or CMV DNAemia…”
Get full text

Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection by Chan, Shuk Ying, Prockop, Susan E, Boulad, Farid, Papanicolaou, Genovefa A, Lee, Yeon Joo

“…Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a…”
Get full text

Disseminated Adenovirus Infection in Cancer Patients Presenting with Focal Pulmonary Consolidation by Lee, Yeon Joo, Palomino-Guilen, Paola, Babady, N Esther, Lamson, Daryl M, St George, Kirsten, Tang, Yi-Wei, Papanicolaou, Genovefa A

“…Classifications Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection by Liu, Xinyan, He, Yaling, Xiao, Kun, White, Julie R, Fusco, Dahlene N, Papanicolaou, Genovefa A

“…Excessive inflammation contributes to the severity of post influenza pneumonia caused by methicillin resistant S.aureus (MRSA). Linezolid, vancomycin, and…”
Get full text

How I prevent viral reactivation in high-risk patients by Dadwal, Sanjeet S., Papanicolaou, Genovefa A., Boeckh, Michael

“…[Display omitted] Preventing viral infections at an early stage is a key strategy for successfully improving transplant outcomes. Preemptive therapy and…”
Get full text

Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study by Zavras, Phaedon, Su, Yiqi, Fang, Jiaqi, Stern, Anat, Gupta, Nitasha, Tang, Yuexin, Raval, Amit, Giralt, Sergio, Perales, Miguel Angel, Jakubowski, Ann A., Papanicolaou, Genovefa A.

“…•We assessed toxicities by day 100 associated with preemptive therapy (PET) in a cohort of cytomegalovirus-seropositive hematopoietic cell transplantation…”
Get full text

Editorial: Friends and foes: “The quarrels of friends are the opportunities of foes” by Neofytos, Dionysios, Papanicolaou, Genovefa A.

Get full text

Determinants of COVID-19 disease severity in patients with cancer by Robilotti, Elizabeth V., Babady, N. Esther, Mead, Peter A., Rolling, Thierry, Perez-Johnston, Rocio, Bernardes, Marilia, Bogler, Yael, Caldararo, Mario, Figueroa, Cesar J., Glickman, Michael S., Joanow, Alexa, Kaltsas, Anna, Lee, Yeon Joo, Lucca, Anabella, Mariano, Amanda, Morjaria, Sejal, Nawar, Tamara, Papanicolaou, Genovefa A., Predmore, Jacqueline, Redelman-Sidi, Gil, Schmidt, Elizabeth, Seo, Susan K., Sepkowitz, Kent, Shah, Monika K., Wolchok, Jedd D., Hohl, Tobias M., Taur, Ying, Kamboj, Mini

“…As of 10 April 2020, New York State had 180,458 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 9,385 reported deaths. Patients with…”
Get full text

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial by Avery, Robin K, Alain, Sophie, Alexander, Barbara D, Blumberg, Emily A, Chemaly, Roy F, Cordonnier, Catherine, Duarte, Rafael F, Florescu, Diana F, Kamar, Nassim, Kumar, Deepali, Maertens, Johan, Marty, Francisco M, Papanicolaou, Genovefa A, Silveira, Fernanda P, Witzke, Oliver, Wu, Jingyang, Sundberg, Aimee K, Fournier, Martha

“…Therapies for refractory cytomegalovirus infections (with or without resistance [R/R]) in transplant recipients are limited by toxicities. Maribavir has…”
Get full text

Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study by Papanicolaou, Genovefa A, Silveira, Fernanda P, Langston, Amelia A, Pereira, Marcus R, Avery, Robin K, Uknis, Marc, Wijatyk, Anna, Wu, Jingyang, Boeckh, Michael, Marty, Francisco M, Villano, Stephen

“…In this multicenter, dose-ranging study of maribavir for the treatment of cytomegalovirus (CMV) infections deemed refractory or resistant to current…”
Get full text

Editorial: Transplant infectious disease landscape in the COVID19-Era by Papanicolaou, Genovefa A., Neofytos, Dionysios

Get full text